Endoscopy Devices Market Size, Share, Trends, Industry Analysis Report
: By Devices Type (Endoscopes, Endoscopy Visualization Systems, Accessories, and Others), By Application, By End Use, and By Region – Market Forecast, 2026–2034
- Published Date: Aug-2025
- Pages: 129
- Format: PDF
- Report ID: PM1131
- Base Year: 2025
- Historical Data: 2021-2024
Endoscopy Devices Market Overview
The global endoscopy devices market size was valued at USD 62.89 billion in 2025. It is expected to grow from USD 64.96 billion in 2026 to USD 86.44 billion by 2034, at a CAGR of 3.6% during 2026–2034. The market is growing due to the increasing preference for minimally invasive surgeries, the rising prevalence of chronic diseases, advancements in endoscopy technology, and the expanding geriatric population requiring diagnostic and therapeutic solutions.
Key Insights
- North America dominated the market with 38.7% revenue share in 2025. The dominance is attributed to the region’s advanced healthcare framework and early adoption of advanced medical technologies.
- In North America, the U.S. accounted for a larger share of 77.5% in 2025. High investments in healthcare innovation and the strong presence of major industry players and technology providers propel the dominance.
- The Asia Pacific market is estimated to record the highest CAGR of 8.5% during the forecast period. Enhanced healthcare framework and growing healthcare disbursement in emerging economies boost the growth.
- The endoscopes segment accounted for the largest market share of 52.3% in 2025. Advances in flexible and rigid endoscope technologies are driving the segment's leading position.
- The hospitals segment is anticipated to exhibit the highest CAGR of 55.7% during the forecast period. This is due to the comprehensive framework and progressive healthcare facilities they provide.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Market Statistics
- 2025 Market Size: USD 62.89 billion
- 2034 Projected Market Size: USD 86.44 billion
- CAGR (2026-2034): 3.6%
- North America: Largest market in 2025
Industry Dynamics
- The growing existence of detrimental illnesses is a prominent driver driving the market as conditions such as cancer, gastrointestinal illnesses, and cardiovascular illnesses growingly need early and precise diagnosis.
- Advances in endoscopy devices play an important part in the accuracy, security, and usability of the devices, which also enable precise diagnosis and minimally invasive procedures.
- The growing geriatric population globally is providing an opportunity to aging persons inclined to acute conditions such as colorectal cancer, gastrointestinal disorders, and orthopedic problems, which need diagnostic and therapeutic endoscopy.
AI Impact on Endoscopy Devices Market
- Artificial intelligence enables real-time detection of polyps, tumors, and abnormal tissues during endoscopic procedures.
- The technology reduces missed lesions in colonoscopy. This supports early diagnosis of colorectal cancer.
- Capsule endoscopy uses AI to analyze thousands of images quickly and efficiently.
- AI-enabled systems are used to automate reporting and reduce procedure time. This AI adoption helps improve workflow.
- AI supports minimally invasive procedures by providing better visualization and clinical decision support.
- Rising gastrointestinal disease cases are increasing demand for AI-enabled endoscopy devices globally.
To Understand More About this Research: Request a Free Sample Report
What are Endoscopy Devices?
Endoscopy devices are medical instruments used to view and operate on the internal organs and vessels of the body through minimally invasive techniques. These devices have become integral to modern healthcare practices as they offer a less intrusive alternative to traditional open surgeries. The endoscopy devices market is growing due to the increasing preference for minimally invasive surgeries. Patients and healthcare providers increasingly favor these procedures due to benefits such as reduced postoperative pain, shorter hospital stays, quicker recovery times, and lower overall healthcare costs. A 2024 NCBI report stated that the US performs over 20 million GI endoscopies yearly, including 6.1 million upper endoscopies and 15 million colonoscopies, reflecting widespread use in diagnostic and preventive care. The adoption of endoscopic procedures across various specialties, such as gastroenterology, urology, and gynecology, continues to strengthen as awareness of these advantages rises.
The increasing geriatric population worldwide is contributing to the endoscopy devices market demand as aging individuals are more prone to chronic conditions such as colorectal cancer, gastrointestinal disorders, and orthopedic issues, many of which require diagnostic or therapeutic endoscopy. There is a consistent surge in the number of elderly patients seeking minimally invasive solutions for diagnosis and treatment, with life expectancy rising globally. An October 2024 WHO report projected that the global population aged 60 and above will rise from 1 billion in 2020 to 1.4 billion by 2030. It is expected to double to 2.1 billion by 2050. Those aged 80 and above will triple to 426 million in the same period. This demographic shift places higher demand on healthcare systems, thereby driving the need for advanced, efficient, and patient-friendly endoscopic devices to support the specialized care requirements of older populations.
Benefits of Endoscopy Devices
- Enables early detection of conditions such as cancers, ulcers, and gastrointestinal disorders.
- Supports minimally invasive procedures with faster recovery and less pain.
- Reduces hospital stay.
- Improves diagnostic accuracy through high-definition imaging and AI integration.
- Expands applications across gastroenterology, pulmonology, urology, and surgery.
Risks Associated with Endoscopy Devices
- High cost of advanced endoscopy systems increases financial burden on hospitals.
- Risk of infection or complications may occur during invasive procedures.
- Shortage of skilled professionals can limit effective device utilization.
- Strict regulatory approvals may delay product launches and market entry.
- Equipment maintenance and sterilization requirements increase operational complexity.
Market Dynamics
Rising Prevalence of Chronic Diseases
The rising prevalence of chronic diseases is a major driver of the endoscopy devices market, as conditions such as cancer, gastrointestinal disorders, and cardiovascular diseases increasingly require early and accurate diagnosis. A December 2024 WHO report stated that noncommunicable diseases caused 43 million deaths in 2021 (75% of non-pandemic deaths). Cardiovascular diseases led to 19 million, followed by cancers, 10 million; chronic respiratory diseases, 4 million; and diabetes, over 2 million, further contributing to the market development. Endoscopy offers a minimally invasive approach to detect and manage these conditions, leading to greater reliance on these devices across healthcare settings. Healthcare providers are adopting endoscopic procedures more frequently to improve patient outcomes and reduce the need for more invasive surgical interventions as the global burden of chronic diseases grows. This trend continues to fuel consistent demand for advanced and specialized endoscopy solutions.
Advancements in Endoscopy Devices
Advancements in endoscopy devices play an essential role in enhancing the precision, safety, and usability of the devices. Innovations such as high-definition imaging, flexible endoscopes, and robotic-assisted procedures have expanded the range of clinical applications for endoscopy, enabling more accurate diagnostics and minimally invasive treatments. In October 2023, Olympus launched its EVIS X1 endoscopy system in the US, along with GIF-1100 and CF-HQ1100DL/I scopes for upper/lower digestive tracts. The lighter ErgoGrip design improves handling and comfort, particularly for users with smaller hands. These technological improvements improve procedural outcomes and also increase the acceptance of endoscopic techniques among both physicians and patients. As a result, continuous innovation in device capabilities supports broader adoption and contributes greatly to the industry growth opportunities.
Segment Insights
Market Assessment by Device Type
The global endoscopy devices market segmentation, based on device type, includes endoscopes, endoscopy visualization systems, accessories, and others. The endoscopes segment accounted for the largest market share of 52.3% in 2025 due to the fundamental role endoscopes play in a wide range of diagnostic and therapeutic procedures. Endoscopes are critical tools in minimally invasive surgeries, offering direct visualization of internal organs with minimal patient trauma. Their widespread adoption across specialties such as gastroenterology, pulmonology, and orthopedics highlights their indispensable value in clinical settings. Furthermore, the continuous advancements in flexible and rigid endoscope technologies have enhanced procedural efficiency and expanded their use in both routine screenings and complex interventions, solidifying their leading position within the market.
Market Evaluation by End Use
The global endoscopy devices market segmentation, based on end use, includes hospitals, outpatient facilities, and others. The hospitals segment is anticipated to exhibit the highest CAGR of 55.7% during the forecast period owing to the comprehensive infrastructure and advanced healthcare facilities they offer. Hospitals are well-equipped to handle a broad spectrum of endoscopic procedures, ranging from diagnostics to complex surgeries, under a single roof. They also benefit from the availability of skilled healthcare professionals and the ability to invest in technologically advanced endoscopy systems. Additionally, the rising number of inpatient and outpatient endoscopic interventions performed in hospitals supports the growing demand for endoscopy devices in this segment.
Regional Analysis
By region, the report provides the endoscopy devices market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market with 38.7% revenue share in 2025 driven by the region’s highly developed healthcare infrastructure and early adoption of advanced medical technologies. Strong healthcare reimbursement policies, increasing preference for minimally invasive procedures, and the high prevalence of chronic diseases contribute immensely to the region's market leadership. A February 2024 CDC report stated that 129 million Americans have at least one major chronic disease, with 42% managing two or more conditions and 12% suffering from five or more. Furthermore, robust investments in healthcare innovation, coupled with a strong presence of major industry players, facilitate the widespread availability and adoption of next-generation laparoscopy and endoscopy devices across hospitals and specialized centers.
The Asia Pacific market is estimated to record the highest CAGR of 8.5% during the forecast period, primarily due to improving healthcare infrastructure and rising healthcare expenditures across emerging economies. An October 2024 report by the Ministry of Health and Family Welfare revealed that Government Health Expenditure (GHE) rose to 1.84% of GDP and 6.12% of General Government Expenditure in 2021–22. Growing awareness about the benefits of early disease detection, coupled with the increasing burden of chronic illnesses, is driving the demand for endoscopic procedures in the region. Additionally, a large and aging population, along with government initiatives to expand access to advanced medical technologies, is expected to accelerate market growth further. This dynamic environment positions Asia Pacific as a key region for the expansion of the laparoscopy and endoscopy devices market.
Key Players and Competitive Landscape
The endoscopy devices market demonstrates robust technological advancement, with players such as Olympus, Boston Scientific, and Karl Storz dominating the market. Emerging competitors such as Fujifilm and Pentax are gaining traction through strategic alliances focused on improved visualization capabilities and miniaturization trends. Customer demand increasingly centers on less invasive procedures with shorter recovery times, driving innovation in disposable laparoscopy and endoscopy devices and AI-assisted diagnostic tools. The competitive positioning landscape is evolving as companies vie to establish superior value propositions through differentiated features rather than price competition alone. Latent demand exists, particularly in emerging economies where healthcare infrastructure development is accelerating. Economic and geopolitical shifts have prompted manufacturers to diversify production facilities and secure alternative component sourcing arrangements, fundamentally altering established industry dynamics. A few key major players are AspireIQ, Inc.; AWISEE; Creator; Grin Technologies Inc.; Heepsy; Insense; IZEA Worldwide, Inc.; Later (Formerly Mavrck); Modash OÜ; NeoReach; SocialEdge, Inc. (CreatorIQ); Takumi International Ltd; TRIBE; and Upfluence.
B. Braun Melsungen AG, headquartered in Germany, is a provider of medical and surgical technologies, including a comprehensive range of endoscopy devices. The company’s endoscopy portfolio is anchored by high-quality rigid endoscopes designed for various minimally invasive procedures such as laparoscopy, arthroscopy, neuroendoscopy, ENT, gynecology, and urology. These endoscopes utilize a glass rod lens system to transmit images from the body cavity to a chip camera, ensuring precise visualization and reliable illumination during surgery. B. Braun’s endoscopes are available in multiple diameters, working lengths, and viewing angles. They can be connected to standard medical chip cameras and light cables from various suppliers, offering flexibility and compatibility in the operating room. The medical devices are engineered for durability, with options for autoclave or chemical sterilization, and are supported by specially designed trays to protect fragile optical components. The company also offers advanced solutions such as the MINOP TREND transnasal endoscopic system for pituitary and skull base surgeries, featuring integrated suction, cleaning, and irrigation functions, as well as Full HD optics for enhanced image quality.
Fujifilm Holdings Corporation, headquartered in Tokyo, Japan, specializes in healthcare technology, with a presence in the endoscopy devices sector. Fujifilm designs, manufactures, and markets advanced medical systems, building on its legacy in imaging and optical innovation. It includes a comprehensive range of endoscopic equipment used for diagnostic and therapeutic procedures across gastroenterology, pulmonology, and surgery. The company’s endoscopy portfolio is renowned for integrating high-definition imaging, proprietary optical technologies, and user-centric ergonomics to enhance visualization and procedural accuracy. Fujifilm’s solutions, such as flexible endoscopes, endoscopic ultrasound systems, and innovative imaging platforms, support early disease detection and minimally invasive interventions. The company’s global reach spans the Americas, Europe, Asia Pacific, and other regions, serving hospitals, clinics, and healthcare providers with both equipment and related medical consumables. Fujifilm’s commitment to research and development ensures continuous product innovation, addressing evolving clinical needs and improving patient outcomes. Its healthcare business, which encompasses endoscopy, is a core pillar alongside material solutions and imaging systems, reflecting the company’s strategic focus on advancing diagnostics services and life sciences.
List of Key Companies in Endoscopy Devices Industry
- Arthrex, Inc.
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Cook Medical
- Fujifilm Holdings Corporation
- Hoya Corporation
- Johnson & Johnson
- KARL STORZ SE & Co. KG
- Medtronic plc
- Olympus Corporation
- PENTAX Medical
- Richard Wolf GmbH
- Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
- STERIS
- Stryker Corporation
Endoscopy Devices Industry Developments
- March 2026: Micro-Tech Endoscopy today announced that it has entered into a definitive agreement to acquire the global distribution rights for the Duraclip™, Precisor®, and Optibite® product lines from CONMED Corporation and which CONMED has sold on behalf of Micro-Tech Endoscopy for over a decade. (Source: mtmed.com)
- May 2025: Olympus Corporation (Japan) revealed that it received FDA 501(k) clearance for its EZ1500 series endoscopes. These endoscopes come with the EDOF technology that enables physicians to get sharp images. (Source: olympusamerica.com)
- December 2024: HOYA Corporation secured FDA 510(k) clearance for new models in the PENTAX Medical i20c Video Endoscope Series. The company noted that the series is designed to assist healthcare professionals in detection, diagnosis, and therapy. (Source: prnewswire.com)
- October 2024: Olympus Europa received CE-MDR approval for Odin Vision’s AI endoscopy tools (CADDIE, CADU, SMARTIBD) in Europe. These cloud-based systems assist in detecting colorectal polyps, Barrett’s Esophagus dysplasia, and ulcerative colitis, enhancing real-time decision-making in endoscopy procedures. (Source: olympus-europa.com)
- August 2024: KARL STORZ and FUJIFILM collaborated to combine advanced OR integration solutions with high-performance GI endoscopes. The collaboration aims to enhance efficiency in surgical suites, hospitals, and ASCs by integrating endoscopic data for improved procedural outcomes. (Source: karlstorz.com)
- March 2024: Scivita Medical expanded its collaboration with Boston Scientific to co-develop future endoscopic devices and distribute Scivita's single-use endoscopes globally, aiming to increase product accessibility in China and other markets. (Source: prnewswire.com)
What is the Future of Endoscopy Devices Market?
The endoscopy devices market is expected to grow steadily in the coming years. AI based tools will improve lesion detection and diagnostic accuracy. Thus, the increasing adoption of AI-assisted diagnostics will propel the market growth. Robotic endoscopy and advanced imaging technologies will enhance precision and procedural efficiency. Rising preference for minimally invasive procedures and the expansion of ambulatory surgical centers will drive demand. Innovation in single-use endoscopes will support infection control and reduce cross-contamination risks. Growing healthcare investments and early disease screening programs are expected to strengthen long-term market expansion.
Endoscopy Devices Market Segmentation
By Devices Type Outlook (Revenue, USD Billion, 2021–2034)
- Endoscopes
- Endoscopy Visualization Systems
- Accessories
- Others
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Laparoscopy
- Bronchoscopy
- Otoscopy
- Arthroscopy
- Urology Endoscopy
- Gastrointestinal Endoscopy
- Others
By End Use Outlook (Revenue, USD Billion, 2021–2034)
- Hospitals
- Outpatient Facilities
- Others
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Endoscopy Devices Market Report Scope
|
Report Attributes |
Details |
|
Market Size Value in 2025 |
USD 62.89 billion |
|
Market Size Value in 2026 |
USD 64.96 billion |
|
Revenue Forecast in 2034 |
USD 86.44 billion |
|
CAGR |
3.6% from 2026 to 2034 |
|
Base Year |
2025 |
|
Historical Data |
2021–2024 |
|
Forecast Period |
2026–2034 |
|
Quantitative Units |
Revenue in USD Billion and CAGR from 2026 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The global market size was valued at USD 62.89 billion in 2025 and is projected to grow to USD 86.44 billion by 2034.
The global market is projected to register a CAGR of 3.6% during the forecast period.
North America dominated the market with 38.7% revenue share in 2025
A few of the key players are AspireIQ, Inc.; AWISEE; Creator; Grin Technologies Inc.; Heepsy; Insense; IZEA Worldwide, Inc.; Later (Formerly Mavrck); Modash OÜ; NeoReach; SocialEdge, Inc. (CreatorIQ); Takumi International Ltd; TRIBE; and Upfluence.
The endoscopes segment accounted for the largest market share of 52.3% in 2025
The hospitals segment is anticipated to exhibit the highest CAGR of 55.7% during the forecast period
© 2026 Polaris Market Research and Consulting. All rights reserved
